Triple negative breast cancer (TNBC), which lacks estrogen receptor-α (ERα), progesterone receptor (PR) and HER2, characteristically includes mutations of DNA damage repair (6), altered PD-L1 expression (7) and increased expression of the G protein coupled receptor CCR5 (8, 9). Here, ERBB2 is linked to triple-negative breast carcinoma.